GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunflower Pharmaceutical Group Co Ltd (SZSE:002737) » Definitions » Deferred Policy Acquisition Costs

Sunflower Pharmaceutical Group Co (SZSE:002737) Deferred Policy Acquisition Costs


View and export this data going back to 2014. Start your Free Trial

What is Sunflower Pharmaceutical Group Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Sunflower Pharmaceutical Group Co (SZSE:002737) Business Description

Traded in Other Exchanges
N/A
Address
Welcome Road, 18 East Lake Road, Harbin High-Tech Industrial Development Zone, Harbin, Heilongjiang, CHN
Sunflower Pharmaceutical Group Co Ltd is engaged in pharmaceutical manufacturing, marketing, and scientific research. The company's product profile include Honeysuckle, Weikangling Granules, Autumn pear moisturizing cream, Vitamin AD drops, Pediatric paracetamol granules, Jianweixiaoshi tablets, Pediatric Chai Gui Antipyretic Granules, Pediatric cough syrup, Kang Fu anti-inflammatory suppository, Xiangsha Yangwei Pills, and others.
Executives
Liu Tian Wei Director
Guan Yu Xiu Director
Wu Guo Xiang Executives
Ren Jing Shang Directors, executives
Guan Yan Bin Directors, executives
Wan Yun Guo Executives
Tian Yan Secretary Dong
Tan Chang Executives
Zhang Quan Director
Xu Qing Fen Supervisors
Jiang Feng He Supervisors
Wu Shu Hua Director
Guan Yan Ling Director
Zhou Jian Zhong Executives